ctrl K

Watchlist Price Alert

SAB Biotherapeutics Inc. (SABS)

NASDAQ: SABS · Real-Time Price · USD

1.93

0.05 (2.82%)

At close: May 14, 2025, 3:50 PM

1.85

-4.15%

After-hours: May 14, 2025, 04:00 PM EDT

SAB Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1.32M	2.24M	23.9M	60.88M	55.24M	3.44M
Cost of Revenue	n/a	3.75M	3.29M	1.65M	n/a	n/a
Gross Profit	-3.47M	-1.51M	20.61M	59.22M	55.24M	3.44M
Operating Income	-42.91M	-38.08M	-28.92M	-13.39M	20.56M	-8.67M
Interest Income	1.29M	584.97K	71.07K	23.11K	26.13K	113.13K
Pretax Income	-34.11M	-42.19M	-18.72M	-17.14M	20.12M	-8.99M
Net Income	-34.11M	-42.19M	-18.74M	-17.44M	20.12M	-9.42M
Selling & General & Admin	13.98M	20.05M	16.38M	17.09M	6.77M	4.1M
Research & Development	30.25M	16.52M	36.44M	57.18M	27.91M	8.02M
Other Expenses	n/a	n/a	-23.9M	-60.88M	4K	2.59K
Operating Expenses	42.91M	36.57M	28.92M	13.39M	34.68M	12.12M
Interest Expense	318.4K	315.28K	301.58K	294.46K	469.15K	428.48K
Selling & Marketing Expenses	n/a	-3.75M	n/a	n/a	n/a	n/a
Cost & Expenses	44.23M	40.31M	28.92M	13.39M	34.68M	12.12M
Income Tax Expense	n/a	n/a	25.63K	299.95K	473.15K	431.07K
Shares Outstanding (Basic)	9.26M	5.52M	4.35M	2.73M	2.54M	43.47M
Shares Outstanding (Diluted)	9.26M	5.52M	4.35M	2.73M	2.7M	43.47M
EPS (Basic)	-3.68	-7.64	-4.31	-6.38	7.92	-0.22
EPS (Diluted)	-3.68	-7.64	-4.31	-6.38	7.45	-0.22
EBITDA	-28.99M	-38.13M	-15.12M	-15.2M	21.14M	-8.23M
EBIT	-33.79M	-41.88M	-18.41M	-16.85M	20.59M	-8.56M
Depreciation & Amortization	4.79M	3.75M	3.29M	1.65M	548.18K	323.41K